Implications of non-prescription antibiotic sales in China

Kalungia, Aubrey and Godman, Brian (2019) Implications of non-prescription antibiotic sales in China. Lancet Infectious Diseases, 19 (12). pp. 1272-1273. ISSN 1473-3099

[thumbnail of Kalungia-Godman-LID-2016-Nonprescription-antibiotic-sales-in-China-and-the]
Text (Kalungia-Godman-LID-2016-Nonprescription-antibiotic-sales-in-China-and-the)
Accepted Author Manuscript
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo

Download (150kB)| Preview


    The Article by Jie Chang and colleagues published in The Lancet Infectious Diseases1 is very timely. It reflects a crucial need for concerted efforts to reduce irrational use of antibiotics to lower rising antimicrobial resistance.2, 3, 4 Overuse has resulted in antibiotics becoming the most commonly used drugs globally.3, 5 Antimicrobial resistance increases morbidity, mortality, and costs because health systems run out of options to treat common infectious diseases.1, 2, 6, 7 Low-income and middle-income countries (LMICs), including China, are a particular concern given their increasing overuse of antibiotics8 coupled with a greater effect of antimicrobial resistance than in high-income countries, because of living conditions, including poor sanitation, malnutrition, and high population density.